nodes	percent_of_prediction	percent_of_DWPC	metapath
Prilocaine—Neurotoxicity—Vincristine—sarcoma	0.0281	0.031	CcSEcCtD
Prilocaine—Respiratory arrest—Thiotepa—sarcoma	0.0279	0.0308	CcSEcCtD
Prilocaine—Neurotoxicity—Etoposide—sarcoma	0.0227	0.0251	CcSEcCtD
Prilocaine—Hypoxia—Thiotepa—sarcoma	0.0193	0.0213	CcSEcCtD
Prilocaine—Paralysis—Vincristine—sarcoma	0.0157	0.0173	CcSEcCtD
Prilocaine—Extravasation—Thiotepa—sarcoma	0.0141	0.0155	CcSEcCtD
Prilocaine—Extravasation—Dactinomycin—sarcoma	0.014	0.0154	CcSEcCtD
Prilocaine—Numbness—Vincristine—sarcoma	0.0131	0.0145	CcSEcCtD
Prilocaine—Neurotoxicity—Epirubicin—sarcoma	0.0128	0.0141	CcSEcCtD
Prilocaine—Sensory loss—Vincristine—sarcoma	0.0126	0.0139	CcSEcCtD
Prilocaine—Extravasation—Vincristine—sarcoma	0.0125	0.0138	CcSEcCtD
Prilocaine—Cyanosis—Etoposide—sarcoma	0.0125	0.0137	CcSEcCtD
Prilocaine—Extravasation—Mitoxantrone—sarcoma	0.0122	0.0134	CcSEcCtD
Prilocaine—Neurotoxicity—Doxorubicin—sarcoma	0.0118	0.013	CcSEcCtD
Prilocaine—Respiratory failure—Vincristine—sarcoma	0.0111	0.0122	CcSEcCtD
Prilocaine—Numbness—Etoposide—sarcoma	0.0106	0.0117	CcSEcCtD
Prilocaine—Neuropathy—Vincristine—sarcoma	0.0102	0.0113	CcSEcCtD
Prilocaine—Sensory loss—Etoposide—sarcoma	0.0102	0.0112	CcSEcCtD
Prilocaine—Extravasation—Etoposide—sarcoma	0.0101	0.0112	CcSEcCtD
Prilocaine—Cardiac failure—Thiotepa—sarcoma	0.00913	0.0101	CcSEcCtD
Prilocaine—Swelling—Mitoxantrone—sarcoma	0.00872	0.00962	CcSEcCtD
Prilocaine—Cardiac arrest—Thiotepa—sarcoma	0.00847	0.00935	CcSEcCtD
Prilocaine—Neuropathy—Etoposide—sarcoma	0.00828	0.00913	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Mitoxantrone—sarcoma	0.00795	0.00877	CcSEcCtD
Prilocaine—Cardiac failure—Mitoxantrone—sarcoma	0.00789	0.0087	CcSEcCtD
Prilocaine—Cardiac arrest—Vincristine—sarcoma	0.00751	0.00829	CcSEcCtD
Prilocaine—Swelling—Etoposide—sarcoma	0.00726	0.00801	CcSEcCtD
Prilocaine—Paralysis—Epirubicin—sarcoma	0.00712	0.00785	CcSEcCtD
Prilocaine—Dermatitis atopic—Epirubicin—sarcoma	0.00668	0.00737	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Etoposide—sarcoma	0.00661	0.0073	CcSEcCtD
Prilocaine—Paralysis—Doxorubicin—sarcoma	0.00658	0.00726	CcSEcCtD
Prilocaine—Cardiac failure—Etoposide—sarcoma	0.00656	0.00724	CcSEcCtD
Prilocaine—Feeling hot—Epirubicin—sarcoma	0.0063	0.00695	CcSEcCtD
Prilocaine—Dermatitis atopic—Doxorubicin—sarcoma	0.00618	0.00682	CcSEcCtD
Prilocaine—Cardiac arrest—Etoposide—sarcoma	0.00609	0.00672	CcSEcCtD
Prilocaine—Neuropathy peripheral—Vincristine—sarcoma	0.00597	0.00659	CcSEcCtD
Prilocaine—Drowsiness—Mitoxantrone—sarcoma	0.00593	0.00654	CcSEcCtD
Prilocaine—Sweating—Vincristine—sarcoma	0.00584	0.00644	CcSEcCtD
Prilocaine—Feeling hot—Doxorubicin—sarcoma	0.00583	0.00643	CcSEcCtD
Prilocaine—Tinnitus—Thiotepa—sarcoma	0.00575	0.00634	CcSEcCtD
Prilocaine—Sweating—Mitoxantrone—sarcoma	0.00569	0.00627	CcSEcCtD
Prilocaine—Extravasation—Epirubicin—sarcoma	0.00567	0.00625	CcSEcCtD
Prilocaine—Arrhythmia—Thiotepa—sarcoma	0.00551	0.00608	CcSEcCtD
Prilocaine—Bronchospasm—Etoposide—sarcoma	0.00544	0.006	CcSEcCtD
Prilocaine—Hypoaesthesia—Vincristine—sarcoma	0.00544	0.006	CcSEcCtD
Prilocaine—Bradycardia—Mitoxantrone—sarcoma	0.00542	0.00598	CcSEcCtD
Prilocaine—Tension—Thiotepa—sarcoma	0.00527	0.00581	CcSEcCtD
Prilocaine—Extravasation—Doxorubicin—sarcoma	0.00524	0.00578	CcSEcCtD
Prilocaine—Dysarthria—Epirubicin—sarcoma	0.00523	0.00577	CcSEcCtD
Prilocaine—Nervousness—Thiotepa—sarcoma	0.00521	0.00575	CcSEcCtD
Prilocaine—Vision blurred—Thiotepa—sarcoma	0.00506	0.00558	CcSEcCtD
Prilocaine—Anaemia—Thiotepa—sarcoma	0.00496	0.00547	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—EZR—sarcoma	0.00494	0.0528	CbGpPWpGaD
Prilocaine—Anaemia—Dactinomycin—sarcoma	0.00492	0.00543	CcSEcCtD
Prilocaine—Dysarthria—Doxorubicin—sarcoma	0.00484	0.00534	CcSEcCtD
Prilocaine—Neuropathy peripheral—Etoposide—sarcoma	0.00484	0.00533	CcSEcCtD
Prilocaine—Arrhythmia—Mitoxantrone—sarcoma	0.00476	0.00525	CcSEcCtD
Prilocaine—SCN2A—L1CAM interactions—EZR—sarcoma	0.00475	0.0508	CbGpPWpGaD
Prilocaine—Neuropathy—Epirubicin—sarcoma	0.00464	0.00512	CcSEcCtD
Prilocaine—Hypertension—Thiotepa—sarcoma	0.00463	0.00511	CcSEcCtD
Prilocaine—SCN1A—L1CAM interactions—EZR—sarcoma	0.00458	0.049	CbGpPWpGaD
Prilocaine—Anxiety—Thiotepa—sarcoma	0.00455	0.00502	CcSEcCtD
Prilocaine—Confusional state—Thiotepa—sarcoma	0.00442	0.00487	CcSEcCtD
Prilocaine—Hypoaesthesia—Etoposide—sarcoma	0.00441	0.00486	CcSEcCtD
Prilocaine—Anaemia—Vincristine—sarcoma	0.0044	0.00485	CcSEcCtD
Prilocaine—Vision blurred—Mitoxantrone—sarcoma	0.00437	0.00482	CcSEcCtD
Prilocaine—Oedema—Dactinomycin—sarcoma	0.00435	0.0048	CcSEcCtD
Prilocaine—Nervous system disorder—Thiotepa—sarcoma	0.0043	0.00474	CcSEcCtD
Prilocaine—Neuropathy—Doxorubicin—sarcoma	0.00429	0.00474	CcSEcCtD
Prilocaine—Anaemia—Mitoxantrone—sarcoma	0.00428	0.00473	CcSEcCtD
Prilocaine—Hypertension—Vincristine—sarcoma	0.00411	0.00453	CcSEcCtD
Prilocaine—Hypertension—Mitoxantrone—sarcoma	0.004	0.00441	CcSEcCtD
Prilocaine—Paraesthesia—Thiotepa—sarcoma	0.00393	0.00434	CcSEcCtD
Prilocaine—Anxiety—Mitoxantrone—sarcoma	0.00393	0.00434	CcSEcCtD
Prilocaine—Somnolence—Thiotepa—sarcoma	0.00389	0.0043	CcSEcCtD
Prilocaine—Anaphylactic shock—Vincristine—sarcoma	0.00388	0.00428	CcSEcCtD
Prilocaine—Oedema—Vincristine—sarcoma	0.00388	0.00428	CcSEcCtD
Prilocaine—Confusional state—Mitoxantrone—sarcoma	0.00381	0.00421	CcSEcCtD
Prilocaine—Nervous system disorder—Vincristine—sarcoma	0.00381	0.0042	CcSEcCtD
Prilocaine—Oedema—Mitoxantrone—sarcoma	0.00378	0.00417	CcSEcCtD
Prilocaine—Anaphylactic shock—Mitoxantrone—sarcoma	0.00378	0.00417	CcSEcCtD
Prilocaine—Hyperhidrosis—Vincristine—sarcoma	0.00376	0.00414	CcSEcCtD
Prilocaine—Pain—Thiotepa—sarcoma	0.00375	0.00413	CcSEcCtD
Prilocaine—Shock—Mitoxantrone—sarcoma	0.00372	0.00411	CcSEcCtD
Prilocaine—Pain—Dactinomycin—sarcoma	0.00372	0.0041	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Epirubicin—sarcoma	0.00371	0.00409	CcSEcCtD
Prilocaine—Cardiac failure—Epirubicin—sarcoma	0.00368	0.00406	CcSEcCtD
Prilocaine—Hyperhidrosis—Mitoxantrone—sarcoma	0.00366	0.00403	CcSEcCtD
Prilocaine—Hypotension—Vincristine—sarcoma	0.00363	0.004	CcSEcCtD
Prilocaine—Feeling abnormal—Thiotepa—sarcoma	0.00361	0.00398	CcSEcCtD
Prilocaine—Diplopia—Epirubicin—sarcoma	0.00359	0.00396	CcSEcCtD
Prilocaine—Osteoarthritis—Epirubicin—sarcoma	0.00359	0.00396	CcSEcCtD
Prilocaine—Feeling abnormal—Dactinomycin—sarcoma	0.00358	0.00395	CcSEcCtD
Prilocaine—Anaemia—Etoposide—sarcoma	0.00356	0.00393	CcSEcCtD
Prilocaine—Hypotension—Mitoxantrone—sarcoma	0.00353	0.0039	CcSEcCtD
Prilocaine—Paraesthesia—Vincristine—sarcoma	0.00349	0.00385	CcSEcCtD
Prilocaine—Urticaria—Thiotepa—sarcoma	0.00348	0.00384	CcSEcCtD
Prilocaine—Anaphylactoid reaction—Doxorubicin—sarcoma	0.00343	0.00378	CcSEcCtD
Prilocaine—Cardiac arrest—Epirubicin—sarcoma	0.00341	0.00376	CcSEcCtD
Prilocaine—Cardiac failure—Doxorubicin—sarcoma	0.0034	0.00375	CcSEcCtD
Prilocaine—Paraesthesia—Mitoxantrone—sarcoma	0.0034	0.00375	CcSEcCtD
Prilocaine—Loss of consciousness—Etoposide—sarcoma	0.00339	0.00374	CcSEcCtD
Prilocaine—Somnolence—Mitoxantrone—sarcoma	0.00336	0.00371	CcSEcCtD
Prilocaine—Hypertension—Etoposide—sarcoma	0.00333	0.00367	CcSEcCtD
Prilocaine—Pain—Vincristine—sarcoma	0.00332	0.00366	CcSEcCtD
Prilocaine—Osteoarthritis—Doxorubicin—sarcoma	0.00332	0.00366	CcSEcCtD
Prilocaine—Diplopia—Doxorubicin—sarcoma	0.00332	0.00366	CcSEcCtD
Prilocaine—Pain—Mitoxantrone—sarcoma	0.00323	0.00357	CcSEcCtD
Prilocaine—Hypersensitivity—Thiotepa—sarcoma	0.00323	0.00356	CcSEcCtD
Prilocaine—SCN5A—L1CAM interactions—EZR—sarcoma	0.00322	0.0344	CbGpPWpGaD
Prilocaine—Hypersensitivity—Dactinomycin—sarcoma	0.0032	0.00353	CcSEcCtD
Prilocaine—Confusional state—Etoposide—sarcoma	0.00317	0.0035	CcSEcCtD
Prilocaine—Cardiac arrest—Doxorubicin—sarcoma	0.00316	0.00348	CcSEcCtD
Prilocaine—Anaphylactic shock—Etoposide—sarcoma	0.00315	0.00347	CcSEcCtD
Prilocaine—Asthenia—Thiotepa—sarcoma	0.00314	0.00347	CcSEcCtD
Prilocaine—Asthenia—Dactinomycin—sarcoma	0.00312	0.00344	CcSEcCtD
Prilocaine—Feeling abnormal—Mitoxantrone—sarcoma	0.00312	0.00344	CcSEcCtD
Prilocaine—Hyperhidrosis—Etoposide—sarcoma	0.00304	0.00336	CcSEcCtD
Prilocaine—Urticaria—Mitoxantrone—sarcoma	0.00301	0.00332	CcSEcCtD
Prilocaine—Hypotension—Etoposide—sarcoma	0.00294	0.00324	CcSEcCtD
Prilocaine—Dizziness—Thiotepa—sarcoma	0.0029	0.0032	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—CXCR4—sarcoma	0.00287	0.0307	CbGpPWpGaD
Prilocaine—Hypersensitivity—Vincristine—sarcoma	0.00286	0.00316	CcSEcCtD
Prilocaine—Paraesthesia—Etoposide—sarcoma	0.00283	0.00312	CcSEcCtD
Prilocaine—Somnolence—Etoposide—sarcoma	0.0028	0.00309	CcSEcCtD
Prilocaine—Hypersensitivity—Mitoxantrone—sarcoma	0.00279	0.00307	CcSEcCtD
Prilocaine—Asthenia—Vincristine—sarcoma	0.00279	0.00307	CcSEcCtD
Prilocaine—Vomiting—Thiotepa—sarcoma	0.00279	0.00307	CcSEcCtD
Prilocaine—Drowsiness—Epirubicin—sarcoma	0.00277	0.00305	CcSEcCtD
Prilocaine—Vomiting—Dactinomycin—sarcoma	0.00276	0.00305	CcSEcCtD
Prilocaine—Asthenia—Mitoxantrone—sarcoma	0.00271	0.00299	CcSEcCtD
Prilocaine—Neuropathy peripheral—Epirubicin—sarcoma	0.00271	0.00299	CcSEcCtD
Prilocaine—Pain—Etoposide—sarcoma	0.00269	0.00297	CcSEcCtD
Prilocaine—Sweating—Epirubicin—sarcoma	0.00265	0.00292	CcSEcCtD
Prilocaine—Nausea—Thiotepa—sarcoma	0.0026	0.00287	CcSEcCtD
Prilocaine—Feeling abnormal—Etoposide—sarcoma	0.00259	0.00286	CcSEcCtD
Prilocaine—Nausea—Dactinomycin—sarcoma	0.00258	0.00285	CcSEcCtD
Prilocaine—Dizziness—Vincristine—sarcoma	0.00257	0.00283	CcSEcCtD
Prilocaine—Drowsiness—Doxorubicin—sarcoma	0.00256	0.00282	CcSEcCtD
Prilocaine—Bradycardia—Epirubicin—sarcoma	0.00253	0.00279	CcSEcCtD
Prilocaine—Neuropathy peripheral—Doxorubicin—sarcoma	0.00251	0.00277	CcSEcCtD
Prilocaine—Urticaria—Etoposide—sarcoma	0.0025	0.00276	CcSEcCtD
Prilocaine—Hypoaesthesia—Epirubicin—sarcoma	0.00247	0.00272	CcSEcCtD
Prilocaine—Vomiting—Vincristine—sarcoma	0.00247	0.00272	CcSEcCtD
Prilocaine—Sweating—Doxorubicin—sarcoma	0.00245	0.00271	CcSEcCtD
Prilocaine—Vomiting—Mitoxantrone—sarcoma	0.00241	0.00265	CcSEcCtD
Prilocaine—Bradycardia—Doxorubicin—sarcoma	0.00234	0.00258	CcSEcCtD
Prilocaine—Hypersensitivity—Etoposide—sarcoma	0.00232	0.00256	CcSEcCtD
Prilocaine—Tinnitus—Epirubicin—sarcoma	0.00231	0.00255	CcSEcCtD
Prilocaine—Nausea—Vincristine—sarcoma	0.00231	0.00255	CcSEcCtD
Prilocaine—Hypoaesthesia—Doxorubicin—sarcoma	0.00229	0.00252	CcSEcCtD
Prilocaine—Asthenia—Etoposide—sarcoma	0.00226	0.00249	CcSEcCtD
Prilocaine—Nausea—Mitoxantrone—sarcoma	0.00225	0.00248	CcSEcCtD
Prilocaine—Arrhythmia—Epirubicin—sarcoma	0.00222	0.00245	CcSEcCtD
Prilocaine—Tinnitus—Doxorubicin—sarcoma	0.00214	0.00236	CcSEcCtD
Prilocaine—Tension—Epirubicin—sarcoma	0.00212	0.00234	CcSEcCtD
Prilocaine—Nervousness—Epirubicin—sarcoma	0.0021	0.00232	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—PDGFRA—sarcoma	0.00208	0.0223	CbGpPWpGaD
Prilocaine—Dizziness—Etoposide—sarcoma	0.00208	0.0023	CcSEcCtD
Prilocaine—Arrhythmia—Doxorubicin—sarcoma	0.00205	0.00226	CcSEcCtD
Prilocaine—Vision blurred—Epirubicin—sarcoma	0.00204	0.00225	CcSEcCtD
Prilocaine—Vomiting—Etoposide—sarcoma	0.002	0.00221	CcSEcCtD
Prilocaine—Anaemia—Epirubicin—sarcoma	0.002	0.0022	CcSEcCtD
Prilocaine—Tension—Doxorubicin—sarcoma	0.00196	0.00216	CcSEcCtD
Prilocaine—Nervousness—Doxorubicin—sarcoma	0.00194	0.00214	CcSEcCtD
Prilocaine—Syncope—Epirubicin—sarcoma	0.00194	0.00214	CcSEcCtD
Prilocaine—Loss of consciousness—Epirubicin—sarcoma	0.0019	0.0021	CcSEcCtD
Prilocaine—Vision blurred—Doxorubicin—sarcoma	0.00188	0.00208	CcSEcCtD
Prilocaine—Nausea—Etoposide—sarcoma	0.00187	0.00206	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—EZR—sarcoma	0.00187	0.02	CbGpPWpGaD
Prilocaine—Hypertension—Epirubicin—sarcoma	0.00187	0.00206	CcSEcCtD
Prilocaine—Anaemia—Doxorubicin—sarcoma	0.00185	0.00204	CcSEcCtD
Prilocaine—Anxiety—Epirubicin—sarcoma	0.00183	0.00202	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—EZR—sarcoma	0.00179	0.0192	CbGpPWpGaD
Prilocaine—Syncope—Doxorubicin—sarcoma	0.00179	0.00198	CcSEcCtD
Prilocaine—Confusional state—Epirubicin—sarcoma	0.00178	0.00196	CcSEcCtD
Prilocaine—Oedema—Epirubicin—sarcoma	0.00176	0.00195	CcSEcCtD
Prilocaine—Anaphylactic shock—Epirubicin—sarcoma	0.00176	0.00195	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—MYOG—sarcoma	0.00176	0.0188	CbGpPWpGaD
Prilocaine—Loss of consciousness—Doxorubicin—sarcoma	0.00176	0.00194	CcSEcCtD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—KDR—sarcoma	0.00175	0.0187	CbGpPWpGaD
Prilocaine—Shock—Epirubicin—sarcoma	0.00174	0.00191	CcSEcCtD
Prilocaine—SCN1A—Axon guidance—EZR—sarcoma	0.00173	0.0185	CbGpPWpGaD
Prilocaine—Nervous system disorder—Epirubicin—sarcoma	0.00173	0.00191	CcSEcCtD
Prilocaine—Hypertension—Doxorubicin—sarcoma	0.00173	0.0019	CcSEcCtD
Prilocaine—Hyperhidrosis—Epirubicin—sarcoma	0.00171	0.00188	CcSEcCtD
Prilocaine—Anxiety—Doxorubicin—sarcoma	0.0017	0.00187	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MYOG—sarcoma	0.00169	0.0181	CbGpPWpGaD
Prilocaine—Hypotension—Epirubicin—sarcoma	0.00165	0.00182	CcSEcCtD
Prilocaine—Confusional state—Doxorubicin—sarcoma	0.00165	0.00182	CcSEcCtD
Prilocaine—Anaphylactic shock—Doxorubicin—sarcoma	0.00163	0.0018	CcSEcCtD
Prilocaine—Oedema—Doxorubicin—sarcoma	0.00163	0.0018	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—MYOG—sarcoma	0.00163	0.0174	CbGpPWpGaD
Prilocaine—SCN5A—Cardiac Progenitor Differentiation—KIT—sarcoma	0.00161	0.0173	CbGpPWpGaD
Prilocaine—Shock—Doxorubicin—sarcoma	0.00161	0.00177	CcSEcCtD
Prilocaine—Nervous system disorder—Doxorubicin—sarcoma	0.0016	0.00177	CcSEcCtD
Prilocaine—Paraesthesia—Epirubicin—sarcoma	0.00158	0.00175	CcSEcCtD
Prilocaine—Hyperhidrosis—Doxorubicin—sarcoma	0.00158	0.00174	CcSEcCtD
Prilocaine—Somnolence—Epirubicin—sarcoma	0.00157	0.00173	CcSEcCtD
Prilocaine—Hypotension—Doxorubicin—sarcoma	0.00152	0.00168	CcSEcCtD
Prilocaine—Pain—Epirubicin—sarcoma	0.00151	0.00166	CcSEcCtD
Prilocaine—Paraesthesia—Doxorubicin—sarcoma	0.00147	0.00162	CcSEcCtD
Prilocaine—Feeling abnormal—Epirubicin—sarcoma	0.00145	0.0016	CcSEcCtD
Prilocaine—Somnolence—Doxorubicin—sarcoma	0.00145	0.0016	CcSEcCtD
Prilocaine—Urticaria—Epirubicin—sarcoma	0.0014	0.00155	CcSEcCtD
Prilocaine—Pain—Doxorubicin—sarcoma	0.0014	0.00154	CcSEcCtD
Prilocaine—Feeling abnormal—Doxorubicin—sarcoma	0.00134	0.00148	CcSEcCtD
Prilocaine—SCN3A—Developmental Biology—EZR—sarcoma	0.00133	0.0142	CbGpPWpGaD
Prilocaine—Hypersensitivity—Epirubicin—sarcoma	0.0013	0.00143	CcSEcCtD
Prilocaine—Urticaria—Doxorubicin—sarcoma	0.0013	0.00143	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—EZR—sarcoma	0.00128	0.0137	CbGpPWpGaD
Prilocaine—Asthenia—Epirubicin—sarcoma	0.00127	0.0014	CcSEcCtD
Prilocaine—SCN1A—Developmental Biology—EZR—sarcoma	0.00123	0.0132	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EZR—sarcoma	0.00122	0.013	CbGpPWpGaD
Prilocaine—Hypersensitivity—Doxorubicin—sarcoma	0.0012	0.00133	CcSEcCtD
Prilocaine—Asthenia—Doxorubicin—sarcoma	0.00117	0.00129	CcSEcCtD
Prilocaine—Dizziness—Epirubicin—sarcoma	0.00117	0.00129	CcSEcCtD
Prilocaine—SCN5A—Developmental Biology—MYOG—sarcoma	0.00115	0.0122	CbGpPWpGaD
Prilocaine—Vomiting—Epirubicin—sarcoma	0.00112	0.00124	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—PTPRC—sarcoma	0.0011	0.0118	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MYOD1—sarcoma	0.00109	0.0116	CbGpPWpGaD
Prilocaine—Dizziness—Doxorubicin—sarcoma	0.00108	0.00119	CcSEcCtD
Prilocaine—SCN3A—Axon guidance—PLCG1—sarcoma	0.00108	0.0115	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—PTPRC—sarcoma	0.00106	0.0113	CbGpPWpGaD
Prilocaine—Nausea—Epirubicin—sarcoma	0.00105	0.00116	CcSEcCtD
Prilocaine—SCN2A—Developmental Biology—MYOD1—sarcoma	0.00104	0.0112	CbGpPWpGaD
Prilocaine—Vomiting—Doxorubicin—sarcoma	0.00104	0.00114	CcSEcCtD
Prilocaine—SCN2A—Axon guidance—PLCG1—sarcoma	0.00103	0.0111	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—PTPRC—sarcoma	0.00102	0.0109	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MYOD1—sarcoma	0.00101	0.0108	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—PLCG1—sarcoma	0.000998	0.0107	CbGpPWpGaD
Prilocaine—Nausea—Doxorubicin—sarcoma	0.000969	0.00107	CcSEcCtD
Prilocaine—SCN3A—L1CAM interactions—SRC—sarcoma	0.000946	0.0101	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—SRC—sarcoma	0.000909	0.00972	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—SRC—sarcoma	0.000876	0.00937	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EZR—sarcoma	0.000868	0.00928	CbGpPWpGaD
Prilocaine—SCN3A—L1CAM interactions—EGFR—sarcoma	0.000829	0.00887	CbGpPWpGaD
Prilocaine—SCN2A—L1CAM interactions—EGFR—sarcoma	0.000797	0.00852	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PTPRC—sarcoma	0.000785	0.0084	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—PLCG1—sarcoma	0.000768	0.00822	CbGpPWpGaD
Prilocaine—SCN1A—L1CAM interactions—EGFR—sarcoma	0.000768	0.00822	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PTPRC—sarcoma	0.000754	0.00807	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—PLCG1—sarcoma	0.000738	0.0079	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PTPRC—sarcoma	0.000728	0.00778	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—PTPRC—sarcoma	0.000717	0.00767	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—PLCG1—sarcoma	0.000712	0.00761	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MYOD1—sarcoma	0.000707	0.00757	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—PLCG1—sarcoma	0.000701	0.0075	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CREB1—sarcoma	0.000648	0.00693	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KDR—sarcoma	0.000632	0.00676	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—SRC—sarcoma	0.000616	0.00659	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KDR—sarcoma	0.000607	0.00649	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KDR—sarcoma	0.000586	0.00626	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—CREB1—sarcoma	0.000554	0.00593	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—FOXO1—sarcoma	0.000545	0.00583	CbGpPWpGaD
Prilocaine—SCN5A—L1CAM interactions—EGFR—sarcoma	0.00054	0.00578	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—CREB1—sarcoma	0.000532	0.00569	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—FOXO1—sarcoma	0.000524	0.0056	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—MMP2—sarcoma	0.000516	0.00552	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—CREB1—sarcoma	0.000513	0.00549	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PTPRC—sarcoma	0.000511	0.00547	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—FOXO1—sarcoma	0.000505	0.0054	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—PLCG1—sarcoma	0.000501	0.00535	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—MMP2—sarcoma	0.000496	0.0053	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—MMP2—sarcoma	0.000478	0.00511	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—JUN—sarcoma	0.000466	0.00498	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—CTNNB1—sarcoma	0.000462	0.00494	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KDR—sarcoma	0.000451	0.00482	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KDR—sarcoma	0.000433	0.00463	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KDR—sarcoma	0.000418	0.00447	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KDR—sarcoma	0.000412	0.0044	CbGpPWpGaD
Prilocaine—SCN5A—SIDS Susceptibility Pathways—VEGFA—sarcoma	0.000407	0.00435	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CREB1—sarcoma	0.000395	0.00423	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CREB1—sarcoma	0.00038	0.00406	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—MMP2—sarcoma	0.000368	0.00394	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CREB1—sarcoma	0.000366	0.00392	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—CREB1—sarcoma	0.000361	0.00386	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—SRC—sarcoma	0.000358	0.00382	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—FOXO1—sarcoma	0.000355	0.0038	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—MMP2—sarcoma	0.000354	0.00378	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—VEGFA—sarcoma	0.000348	0.00372	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—NRAS—sarcoma	0.000344	0.00368	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—SRC—sarcoma	0.000343	0.00367	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—MMP2—sarcoma	0.000341	0.00365	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—MMP2—sarcoma	0.000336	0.00359	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—VEGFA—sarcoma	0.000335	0.00358	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—SRC—sarcoma	0.000331	0.00354	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—NRAS—sarcoma	0.00033	0.00353	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—VEGFA—sarcoma	0.000323	0.00345	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—NRAS—sarcoma	0.000319	0.00341	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—EGFR—sarcoma	0.000313	0.00335	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—EGFR—sarcoma	0.000301	0.00322	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—KRAS—sarcoma	0.000296	0.00317	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KDR—sarcoma	0.000294	0.00314	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—EGFR—sarcoma	0.00029	0.0031	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—KRAS—sarcoma	0.000284	0.00304	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—CTNNB1—sarcoma	0.000282	0.00302	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—KRAS—sarcoma	0.000274	0.00293	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—CTNNB1—sarcoma	0.000271	0.0029	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—CTNNB1—sarcoma	0.000261	0.0028	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CREB1—sarcoma	0.000258	0.00275	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—SRC—sarcoma	0.000255	0.00273	CbGpPWpGaD
Prilocaine—SCN3A—Axon guidance—HRAS—sarcoma	0.000252	0.00269	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—VEGFA—sarcoma	0.000248	0.00266	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—NRAS—sarcoma	0.000245	0.00262	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—SRC—sarcoma	0.000245	0.00262	CbGpPWpGaD
Prilocaine—SCN2A—Axon guidance—HRAS—sarcoma	0.000242	0.00259	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—MMP2—sarcoma	0.00024	0.00256	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—VEGFA—sarcoma	0.000239	0.00255	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—SRC—sarcoma	0.000236	0.00253	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—NRAS—sarcoma	0.000236	0.00252	CbGpPWpGaD
Prilocaine—SCN1A—Axon guidance—HRAS—sarcoma	0.000233	0.00249	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—SRC—sarcoma	0.000233	0.00249	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—VEGFA—sarcoma	0.00023	0.00246	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—NRAS—sarcoma	0.000227	0.00243	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—VEGFA—sarcoma	0.000227	0.00243	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—NRAS—sarcoma	0.000224	0.0024	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—EGFR—sarcoma	0.000224	0.00239	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—EGFR—sarcoma	0.000215	0.0023	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—KRAS—sarcoma	0.000211	0.00226	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—EGFR—sarcoma	0.000207	0.00222	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—EGFR—sarcoma	0.000204	0.00218	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—KRAS—sarcoma	0.000203	0.00217	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—KRAS—sarcoma	0.000196	0.00209	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—KRAS—sarcoma	0.000193	0.00206	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—CTNNB1—sarcoma	0.000184	0.00197	CbGpPWpGaD
Prilocaine—SCN3A—Developmental Biology—HRAS—sarcoma	0.00018	0.00192	CbGpPWpGaD
Prilocaine—SCN2A—Developmental Biology—HRAS—sarcoma	0.000173	0.00184	CbGpPWpGaD
Prilocaine—SCN1A—Developmental Biology—HRAS—sarcoma	0.000166	0.00178	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—SRC—sarcoma	0.000166	0.00178	CbGpPWpGaD
Prilocaine—SCN5A—Axon guidance—HRAS—sarcoma	0.000164	0.00175	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—VEGFA—sarcoma	0.000162	0.00173	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—NRAS—sarcoma	0.00016	0.00171	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—EGFR—sarcoma	0.000146	0.00156	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—KRAS—sarcoma	0.000138	0.00147	CbGpPWpGaD
Prilocaine—SCN5A—Developmental Biology—HRAS—sarcoma	0.000117	0.00125	CbGpPWpGaD
